Results 171 to 180 of about 8,127 (213)

Integration of 16S rRNA sequencing and metabolomics to investigate the modulatory effect of ginsenoside Rb1 on atherosclerosis. [PDF]

Heliyon
Liang Y, Fu J, Shi Y, Jiang X, Lu F, Liu S.   +5 more
europepmc   +1 more source

Ginsenoside Rb1 Alleviates DSS-Induced Ulcerative Colitis by Protecting the Intestinal Barrier Through the Signal Network of VDR, PPARγ and NF-κB. [PDF]

Drug Des Devel Ther
Zhou Y, Xiong X, Cheng Z, Chen Z, Wu S, Yu Y, Liu Y, Chen G, Li L.   +8 more
europepmc   +1 more source

Kampo-pharmaceutics [PDF]

, 2007
白 雪, 鹿野 美弘
core   +2 more sources

Ginsenoside Rb1 prevents age-related endothelial senescence by modulating SIRT1/caveolin-1/enos signaling pathway. [PDF]

Heliyon
Zhou B, Sh G, Xie D, Zhao X, Hao B, Liu D, Wang M, Wu L, Lin L, Qian X.   +9 more
europepmc   +1 more source

Ginsenoside Rb₁ Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway. [PDF]

Pharmaceuticals (Basel)
Zhou Z, Song Z, Guo X, Wang Q, Li M, Zhang M, Gong M.   +6 more
europepmc   +1 more source

Methanol-involved heterogeneous transformation of ginsenoside Rb1 to rare ginsenosides using heteropolyacids embedded in mesoporous silica with HPLC-MS investigation. [PDF]

J Ginseng Res
Zhao M, Xiao Y, Chang Y, Tian L, Zhou Y, Liu S, Zhao H, Xiu Y.   +7 more
europepmc   +1 more source

Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis. [PDF]

J Pharm Anal
Lin L, Li X, Li Y, Lang Z, Li Y, Zheng J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Conversion of Major Ginsenoside Rb1 to Ginsenoside F2 by Caulobacter leidyia

Biotechnology Letters, 2006
Ginsenoside Rb1 is the most predominant ginsenoside in Panax species (ginseng) and the hydrolysis of this ginsenoside produces pharmaceutically active compounds. Caulobacter leidyia GP45, one of the isolates having strong beta-glucosidase-producing activity, converted ginsenoside Rb(1) to the active metabolites by 91%.
Le-Qin, Cheng, Myung Kyum, Kim, Jun-Won, Lee, Youn-Jin, Lee, Deok-Chun, Yang   +4 more
openaire   +4 more sources

Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514

Phytochemistry, 2008
Ginseng saponin, the most important secondary metabolite in ginseng, has various pharmacological activities. Many studies have been directed towards converting major ginsenosides to the more active minor ginsenoside, Rg3. Due to the difficulty in preparing ginsenoside Rg3 enzymatically, the compound has been mainly produced by either acid treatment or ...
Le-Qin, Cheng, Ju Ryun, Na, Myun Ho, Bang, Myung Kyum, Kim, Deok-Chun, Yang   +4 more
openaire   +4 more sources

Ginsenoside Rb1 Suppresses AOM/DSS-induced Colon Carcinogenesis

Anti-Cancer Agents in Medicinal Chemistry, 2023
Background: Colorectal cancer (CRC) is the third most common cancer worldwide. Current treatments, including surgery, radiotherapy, and chemotherapy, are limited by severe side effects and the development of resistance. Objective: Therefore, it is important to find additional therapies to combat the problem.
Ling, Wang, Qing-Qing, Zhang, Yu-Yu, Xu, Rui, Zhang, Qing, Zhao, Yu-Qing, Zhang, Xue-Hong, Huang, Bin, Jiang, Min, Ni   +8 more
openaire   +2 more sources